Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.

Gianluca Iacobellis, M. Iorio, N. Napoli, D. Cotesta, L. Zinnamosca, C. Marinelli, L. Petramala, S. Minisola, E. D'Erasmo, C. Letizia

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Adipose tissue has been suggested to influence bone density and metabolism through the effect of some adipokines. However, whether adiponectin and visfatin may correlate with bone metabolism is still unclear. The aim of this study was to investigate the relationship of adiponectin and visfatin with bone density in patients with metabolic syndrome (MS). We enroled 72 consecutive patients with MS (25 males, 47 females; mean age 58.14±11 yr) and 40 control subjects. Plasma adiponectin and visfatin levels were measured. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry (DXA) at the level of lumbar spine L2-L4 (BMD L2-L4) and femoral neck (BMD-Fn). MS patients had higher plasma visfatin and lower adiponectin levels than controls, (p<0.01 for both). Adiponectin was negatively correlated with BMD-Fn and BMD L2-L4 (r=-0.20, r=-0.24, respectively; p<0.05 for both) whereas plasma visfatin levels were positively correlated to BMD L2-L4 only in men (r=0.44; p<0.05). Our study shows that adiponectin and visfatin are oppositely associated with BMD. Although the mechanisms behind these correlations are unclear, a modulation of bone metabolism by these adipokines can be suggested.

Original languageEnglish
JournalJournal of Endocrinological Investigation
Volume34
Issue number1
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Nicotinamide Phosphoribosyltransferase
Adiponectin
Bone Density
Adipokines
Bone and Bones
Femur Neck
Photon Absorptiometry
Adipose Tissue
Spine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Iacobellis, G., Iorio, M., Napoli, N., Cotesta, D., Zinnamosca, L., Marinelli, C., ... Letizia, C. (2011). Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. Journal of Endocrinological Investigation, 34(1).

Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. / Iacobellis, Gianluca; Iorio, M.; Napoli, N.; Cotesta, D.; Zinnamosca, L.; Marinelli, C.; Petramala, L.; Minisola, S.; D'Erasmo, E.; Letizia, C.

In: Journal of Endocrinological Investigation, Vol. 34, No. 1, 01.01.2011.

Research output: Contribution to journalArticle

Iacobellis, G, Iorio, M, Napoli, N, Cotesta, D, Zinnamosca, L, Marinelli, C, Petramala, L, Minisola, S, D'Erasmo, E & Letizia, C 2011, 'Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.', Journal of Endocrinological Investigation, vol. 34, no. 1.
Iacobellis, Gianluca ; Iorio, M. ; Napoli, N. ; Cotesta, D. ; Zinnamosca, L. ; Marinelli, C. ; Petramala, L. ; Minisola, S. ; D'Erasmo, E. ; Letizia, C. / Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. In: Journal of Endocrinological Investigation. 2011 ; Vol. 34, No. 1.
@article{757cbaa53ee14b40a13432ed7b27b197,
title = "Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.",
abstract = "Adipose tissue has been suggested to influence bone density and metabolism through the effect of some adipokines. However, whether adiponectin and visfatin may correlate with bone metabolism is still unclear. The aim of this study was to investigate the relationship of adiponectin and visfatin with bone density in patients with metabolic syndrome (MS). We enroled 72 consecutive patients with MS (25 males, 47 females; mean age 58.14±11 yr) and 40 control subjects. Plasma adiponectin and visfatin levels were measured. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry (DXA) at the level of lumbar spine L2-L4 (BMD L2-L4) and femoral neck (BMD-Fn). MS patients had higher plasma visfatin and lower adiponectin levels than controls, (p<0.01 for both). Adiponectin was negatively correlated with BMD-Fn and BMD L2-L4 (r=-0.20, r=-0.24, respectively; p<0.05 for both) whereas plasma visfatin levels were positively correlated to BMD L2-L4 only in men (r=0.44; p<0.05). Our study shows that adiponectin and visfatin are oppositely associated with BMD. Although the mechanisms behind these correlations are unclear, a modulation of bone metabolism by these adipokines can be suggested.",
author = "Gianluca Iacobellis and M. Iorio and N. Napoli and D. Cotesta and L. Zinnamosca and C. Marinelli and L. Petramala and S. Minisola and E. D'Erasmo and C. Letizia",
year = "2011",
month = "1",
day = "1",
language = "English",
volume = "34",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "1",

}

TY - JOUR

T1 - Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.

AU - Iacobellis, Gianluca

AU - Iorio, M.

AU - Napoli, N.

AU - Cotesta, D.

AU - Zinnamosca, L.

AU - Marinelli, C.

AU - Petramala, L.

AU - Minisola, S.

AU - D'Erasmo, E.

AU - Letizia, C.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Adipose tissue has been suggested to influence bone density and metabolism through the effect of some adipokines. However, whether adiponectin and visfatin may correlate with bone metabolism is still unclear. The aim of this study was to investigate the relationship of adiponectin and visfatin with bone density in patients with metabolic syndrome (MS). We enroled 72 consecutive patients with MS (25 males, 47 females; mean age 58.14±11 yr) and 40 control subjects. Plasma adiponectin and visfatin levels were measured. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry (DXA) at the level of lumbar spine L2-L4 (BMD L2-L4) and femoral neck (BMD-Fn). MS patients had higher plasma visfatin and lower adiponectin levels than controls, (p<0.01 for both). Adiponectin was negatively correlated with BMD-Fn and BMD L2-L4 (r=-0.20, r=-0.24, respectively; p<0.05 for both) whereas plasma visfatin levels were positively correlated to BMD L2-L4 only in men (r=0.44; p<0.05). Our study shows that adiponectin and visfatin are oppositely associated with BMD. Although the mechanisms behind these correlations are unclear, a modulation of bone metabolism by these adipokines can be suggested.

AB - Adipose tissue has been suggested to influence bone density and metabolism through the effect of some adipokines. However, whether adiponectin and visfatin may correlate with bone metabolism is still unclear. The aim of this study was to investigate the relationship of adiponectin and visfatin with bone density in patients with metabolic syndrome (MS). We enroled 72 consecutive patients with MS (25 males, 47 females; mean age 58.14±11 yr) and 40 control subjects. Plasma adiponectin and visfatin levels were measured. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry (DXA) at the level of lumbar spine L2-L4 (BMD L2-L4) and femoral neck (BMD-Fn). MS patients had higher plasma visfatin and lower adiponectin levels than controls, (p<0.01 for both). Adiponectin was negatively correlated with BMD-Fn and BMD L2-L4 (r=-0.20, r=-0.24, respectively; p<0.05 for both) whereas plasma visfatin levels were positively correlated to BMD L2-L4 only in men (r=0.44; p<0.05). Our study shows that adiponectin and visfatin are oppositely associated with BMD. Although the mechanisms behind these correlations are unclear, a modulation of bone metabolism by these adipokines can be suggested.

UR - http://www.scopus.com/inward/record.url?scp=79959786213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959786213&partnerID=8YFLogxK

M3 - Article

VL - 34

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 1

ER -